Clinical Trials Logo

Clinical Trial Summary

In order to better guide clinical medication, verify the efficacy and safety of ABCD in the treatment of various invasive fungal disease, the investigators have designed a multi-center, retrospective registration study. Diagnosis and treatment data for patients with different types of invasive fungal disease in clinical actual environment was collapsed by a database for collaborative exchange on antifungal research.


Clinical Trial Description

This study is a retrospective, non-interventional, and observational study. The clinical data of the patient during hospitalization shall be collected at least 2 weeks after the end of the ABCD drug, including basic data of the patient, laboratory data and clinical treatment, mainly covering antifungal medications, such as pretreatment measures, drug dosage and dispensing method, route of administration, duration of administration, efficacy and adverse reactions, etc. If adverse events related to ABCD have not ended after 2 weeks, investigators are advised to follow up until the adverse events recover or stabilize. It is hoped that the basic situation of Chinese invasive fungal patients is described, and ABCD is evaluated in the treatment of invasive fungal patients. In addition, prognostic factors can be analyzed to optimize clinical medication regimen and provide basis support for clinical medication of ABCD. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05116059
Study type Observational
Source Peking Union Medical College Hospital
Contact zhengyin Liu
Phone 010-69156114
Email [email protected]
Status Not yet recruiting
Phase
Start date November 20, 2021
Completion date December 31, 2022

See also
  Status Clinical Trial Phase
Completed NCT01916057 - Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis N/A
Completed NCT03262584 - Evaluation of NGS for Detection and Follow-up of Fungal Pathogens in Immunocompromised Pediatric Patients
Recruiting NCT04368559 - Study of Rezafungin Compared to Standard Antimicrobial Regimen for Prevention of Invasive Fungal Diseases in Adults Undergoing Allogeneic Blood and Marrow Transplantation Phase 3
Recruiting NCT01731353 - Fungiscope - A Global Emerging Fungal Infection Registry N/A
Completed NCT03577509 - Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China Phase 1
Recruiting NCT03774316 - De-escalation - Antifungal Treatment Immunocompromised Patients
Completed NCT01259713 - Prevention of Invasive Fungal Infections (IFIs) in Subjects Receiving Chemotherapy for Acute Lymphoblastic Leukemia Phase 3
Recruiting NCT01135589 - Micafungin Prevention Study for Fungal Disease in Child Receiving Allogenic Hematopoietic Stem Cell Transplantation Phase 4